Hpv Vaccination clinical trials

Explore recruiting hpv vaccination clinical trials.

Recruiting hpv vaccination studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hpv Vaccination trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HPV2-2303 - Phase 2 clinical trial evaluating secondary HPV vaccination after treatment of high-grade cervical lesions

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Human papillomavirus vaccine effectiveness study among men who have sex with men

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

VulVaccin study: Adjuvant nonavalent HPV vaccination in women treated for vulvar HSIL, a Randomised Placebo Controlled Trial.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.(BioHPV)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination in women treated with loop electrosurgical excision (LEEP) for high-grade cervical intraepithelial neoplasia (CIN2+) up to cervical cancer initially invasive (FIGO IA1) - HOPE 9 STUDY

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hpv Vaccination trials by city

Hpv Vaccination in Toronto Hpv Vaccination in Vancouver Hpv Vaccination in Montreal Hpv Vaccination in Calgary Hpv Vaccination in Edmonton Hpv Vaccination in Ottawa Hpv Vaccination in Winnipeg Hpv Vaccination in Quebec City Hpv Vaccination in Hamilton Hpv Vaccination in Kitchener Hpv Vaccination in London Hpv Vaccination in Halifax Hpv Vaccination in New York Hpv Vaccination in Los Angeles Hpv Vaccination in Chicago Hpv Vaccination in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease